TAKE THE STRAIN

Covid vaccine to beat South African variant ‘ready by Autumn’ as minister says Oxford jab will still prevent deaths

A CORONAVIRUS jab which can beat the South African variant could be ready as soon as Autumn, scientists have said. 

It comes as vaccine minister Nadhim Zahawi assured Brits that the Oxford jab would still prevent deaths - despite a study suggesting it was less effective against mild disease caused by the strain.

Advertisement

🦠 Read our coronavirus live blog for the latest news & updates

in a bid to contain the spread.

The study - conducted by South Africa's University of the Witwatersrand and Oxford University - found that the jab "provides minimal protection" against moderate Covid-19 caused by the variant.

However, researchers still believe the Oxford vaccine is effective in preventing severe disease, hospital admissions and deaths, and also works well against the original coronavirus strain.

Advertisement
today, Mr Zahawi said that the emergence of new variants was “worrying” - but stressed that the vaccines were still effective against the dominant strains. 

He wrote: “We should bear in mind that recent studies show the vaccines being deployed right now across the UK appear to work well against the Covid-19 variants currently dominant in the UK.

“In terms of other variants, not in the UK, we need to be aware that even where a vaccine has reduced efficacy in preventing infection there may still be good efficacy against severe disease, hospitalisation, and death. 

“This is vitally important for protecting the healthcare system.”

Advertisement

JAB HOPE

Mr Zahawi warned the country may need a rolling programme with annual jabs or a booster in the autumn to protect against the mutant strains.

Professor Sarah Gilbert, lead researcher in the Oxford team, said scientists were already tweaking the jab to respond to mutations - and a revised vaccine could be rolled out as soon as Autumn. 

She told the BBC’s Andrew Marr show yesterday: “We have a version with the South African spike sequence in the works. It’s not quite ready to vaccinate people yet.

“It’s easy to adapt the technology, develop a new vaccine which will have to go through a small amount of clinical testing, not nearly the same amount as we had to go through last year.”

Advertisement
Topics
Advertisement
machibet777.com